HIGHLIGHTS
- who: Anton Amadeus Hu00f6rmann and colleagues from the Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria have published the paper: Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R, in the Journal: Pharmaceutics 2023, 15, 796. of /2023/
- what: In this study further N-terminal peptide modifications were investigated. In the attempt to investigate possible alternative stabilization strategies in this study, the effect of the N-terminal modifications within the peptide sequence on the in_vitro and in_vivo CCK2R-targeting properties was evaluated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.